Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review

Many men have coexistent erectile dysfunction (ED) and lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH). Phosphodiesterase type 5 (PDE5) inhibitors are effective for treating both of these conditions independently. In this review we summarise the evidence supporting...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Albert, Jabbour, Michel, Bulbul, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563010/
https://www.ncbi.nlm.nih.gov/pubmed/26413339
http://dx.doi.org/10.1016/j.aju.2015.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563010/
https://www.ncbi.nlm.nih.gov/pubmed/26413339
http://dx.doi.org/10.1016/j.aju.2015.06.004

Ejemplares similares